InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

LJ

London, John

OFFICER

Crescita Therapeutics Inc.

Cumul. flow

0

Total declarations

0

Company

€172,314

▲ Purchases (5 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

5

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the full record of transactions filed by London, John. Director active across 1 company, notably Crescita Therapeutics Inc.. Cumulatively, 6 reports have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €172k. History available since 3 June 2026. The latest transaction was disclosed on 3 June 2026 (22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition). Regulator: SEDI. The full history is free.

Declarations6 total

▲

4 - Director of IssuerExecutives3 Jun 2026Crescita Therapeutics Inc.

CA$76,21836SEDI ↗

95,273 shares@ CA$0.8027.4% of flowDeferred Share Units (DSU)TSXSEDI:4732049

Ideal exit: 28 Feb 2027 (T+270)

◇

4 - Director of IssuerExecutives6 May 2024Crescita Therapeutics Inc.

59,158 sharesOptionsTSXSEDI:4732046

▲

4 - Director of IssuerExecutives3 Jun 2026Crescita Therapeutics Inc.

CA$46,80035SEDI ↗

58,500 shares@ CA$0.8016.8% of flowOptionsTSXSEDI:4732045

Ideal exit: 28 Feb 2027 (T+270)

▲

4 - Director of IssuerExecutives3 Jun 2026Crescita Therapeutics Inc.

CA$24,15035SEDI ↗

30,188 shares@ CA$0.8015.6% of flowCommon SharesTSXSEDI:4732010

Ideal exit: 28 Feb 2027 (T+270)

▲

4 - Director of IssuerExecutives3 Jun 2026Crescita Therapeutics Inc.

CA$6,03833SEDI ↗

7,548 shares@ CA$0.803.9% of flowCommon SharesTSXSEDI:4732009

Ideal exit: 28 Feb 2027 (T+270)

▲

4 - Director of IssuerExecutives3 Jun 2026Crescita Therapeutics Inc.

CA$124,62941SEDI ↗

155,786 shares@ CA$0.8080.5% of flowCommon SharesTSXSEDI:4732008

Ideal exit: 28 Feb 2027 (T+270)

6 of 6 declarations